One hundred ninety-one patients with recurrent or metastatic squamous cell carcinoma of head and neck origin were allocated at random to chemotherapy with conventional-dose weekly intravenous methotrexate or the combination of cisplatin, vinblastine, and bleomycin. Methotrexate induced responses in
Vinblastine, methotrexate, bleomycin, in the management of head and neck cancer
β Scribed by C. Vanhaelen; M. Bertrand; R. De Jager; Y. Kenis
- Book ID
- 113146266
- Publisher
- Elsevier Science
- Year
- 1979
- Weight
- 275 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0014-2964
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Objective: To explore whether the combined radiochemotherapy with Vinblastine, Methotrexate, and Bleomycin could be an effective alternative treatment to surgery in verrucous carcinoma (VC) of the head and neck. Methods: Combined radiochemotherapy was used in 12 patients with previously untreated VC
## Abstract A combination of cyclophosphamide, adriamycin, methotrexate, and bleomycin (CAMB) was explored in patients with advanced, nonresectable epidermoid carcinoma from primary sites in the head and neck, recurrent or persistent after radiation or surgery. Objective regression (greater than 50
Combination chemotherapy with methotrexate, bleomycin, and cis-diamminedichloroplatinum (11) was compared to weekly therapy with methotrexate alone in a randomized prospective trial in 163 patients with recurrent or metastatic squamous cancer of the mucous membranes of the head and neck. The combina